Evidence map›Paper›PMID 39854578›Full record

Trial reportPloS one2025

Randomized clinical trial of ICECaP (Individualized Coordination and Empowerment for Care Partners of Persons with Dementia): Primary mental health and burden outcomes.

Virginia T Gallagher, Anna Arp, Ryan Thompson, M Agustina Rossetti, James Patrie, Shannon E Reilly, Carol Manning

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Virginia T GallagherDepartment of Neurology, University of Virginia, Charlottesville, Virginia, United States of America.ORCID 0000-0002-3526-0828
Anna ArpBrain Institute, University of Virginia, Charlottesville, Virginia, United States of America.ORCID 0009-0003-6662-9856
Ryan ThompsonDepartment of Neurology, University of Virginia, Charlottesville, Virginia, United States of America.
M Agustina RossettiDepartment of Neurology, University of Virginia, Charlottesville, Virginia, United States of America.ORCID 0000-0003-0561-6405
James PatrieDepartment of Biostatistics, University of Virginia, Charlottesville, Virginia, United States of America.
Shannon E ReillyDepartment of Neurology, University of Virginia, Charlottesville, Virginia, United States of America.ORCID 0000-0003-2279-0595
Carol ManningDepartment of Neurology, University of Virginia, Charlottesville, Virginia, United States of America.

Funding

The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve HealthUL1TR003015 · NCATS · UNIVERSITY OF VIRGINIA · PI BROWN, DONALD E, JOHNSTON, KAREN C. · 2019 to 2023
$20.3M
Institutional Career Development CoreKL2TR003016 · NCATS · UNIVERSITY OF VIRGINIA · PI PAPIN, JASON, WORRALL, BRADFORD B · 2019 to 2023
$3.9M
DOD Deparment of Defense AZ190036NCATS NIH HHS KL2 TR003016NCATS NIH HHS UL1 TR003015
6 · The paper itself

Abstract

We examine the efficacy of the Individualized Coordination and Empowerment for Care Partners of Persons with Dementia (ICECaP), an intervention that involves one-on-one individualized support from a dementia care coordinator for a dementia care partner, compared to an active control group. At least once monthly contact is made from a dementia care coordinator to the dementia care partner by telephone, video conferencing, email, or in-person support at clinical visits for the person with dementia. In this pilot randomized unblinded control trial of ICECaP, n = 61 (n = 90 randomized) care partners completed 12-months of the ICECaP intervention and n = 69 (n = 92 randomized) care partners received routine clinical support (controls) in an outpatient memory care clinic at an academic medical center, from which the participants were recruited. Early termination endpoints (death and higher level of care) and trial drop out were comparable across groups. Primary efficacy outcomes were evaluated by comparing changes in care partner mental health, burden, and quality of life from baseline to 12-months between ICECaP and controls. Linear mixed-effects model with covariate adjustment revealed no significant group differences in longitudinal changes on measures of caregiving burden, care partner depression, anxiety, quality of life, or reactions to the behavioral symptoms of the person with dementia. Hypothesized reasons for lack of initial efficacy on primary 12-month outcomes are discussed.

Indexed as

CaregiversDementiaEmpowermentMental HealthAgedAged, 80 and overFemaleHumansMaleMiddle AgedPilot ProjectsQuality of Life

Identifiers

PMID39854578
PMCPMC11760562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.